On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
FridaySep 21, 2018 5:01 pm

NetworkNewsBreaks – Golden Developing Solutions, Inc. (DVLP) Acquires WheresWeed.com

Golden Developing Solutions (OTCMKTS: DVLP), an emerging leader in the Cannabis sector, recently acquired Where’s Weed (Layer Six Media LLC DBA “Wheres Weed”), and its primary asset, WheresWeed.com. The site currently brings in more than 2.9 million page views per month. As a budding community-based online resource for cannabis consumers, Where’s Weed also offers a variety of user-friendly services, including a mobile app with over 80k downloads. “Where’s Weed is a perfect complementary piece of the puzzle for DVLP right now. The growth potential for this additional segment is enormous and will powerfully benefit from an infusion of capital. We…

Continue Reading

FridaySep 21, 2018 2:14 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Platform Demonstrates Excellent Results in Delivery of APIs to the Brain

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative delivery platform, DehydraTECH™, has demonstrated excellent results in delivery of nicotine to the brain in a recent lab study. An article discussing this reads, “The new report confirmed first generation results of in vivo tests on live animals showing that DehydraTECH™ was able to deliver more active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, as reported in an article published by the CFN Media Group (http://nnw.fm/oN1Xp). Because of certain similarities in physical structure between the nicotine molecule and several of the drugs used to treat diseases such as Huntington’s, Parkinson’s,…

Continue Reading

FridaySep 21, 2018 2:07 pm

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Strategically Employs R&D Strategy to Achieve Increased Productivity

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) aims to give its investors more bang for their buck when it comes to research and development (“R&D”), as it has been proven that smaller companies achieve higher R&D productivity. A recent article discussing the company reads: “PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has taken this advice to heart. The health sciences company has three distinct research programs underway. Top of the line is a non-opioid pain treatment based on cannabinoids to be administered through a proprietary nose-to-brain, soluble gel (Sol-gel) drug delivery system. The research…

Continue Reading

FridaySep 21, 2018 1:46 pm

NetworkNewsBreaks – The Flowr Corp. and The Needle Capital Corp. Successfully Complete Qualifying Transaction

The Flowr Corp., a vertically-integrated Canadian licensed producer that focuses primarily on premium flower production, together with The Needle Capital Corp., this morning announced the successful completion of the qualifying transaction under the policies of the TSX Venture Exchange (the “TSXV”). In accordance with a business combination agreement entered into between Needle, Flowr and 2652253 Ontario Inc. ("Subco"), Needle and Flowr completed a transaction that resulted in a reverse takeover of Needle by the shareholders of Flowr to form the resulting issuer. Flowr and Needle attained conditional approval for the transaction from the TSXV on September 12, 2018 and the…

Continue Reading

FridaySep 21, 2018 12:40 pm

NetworkNewsBreaks – CashDirector to Present at FinovateFall Conference

CashDirector this morning announced that it will be presenting its virtual CFO, artificial intelligence (“AI”)-based robo-accounting platforms at FinovateFall, a global conference in New York City taking place September 24-27, 2018. FinovateFall is anticipated to bring over 1,500 attendees, 100 expert speakers, and 80 companies together to share insights and offer solutions to challenges facing the fintech industry. The three-day conference is set to take place at the New York Marriott Marquis Hotel September 24-26, with an add-on summit day on September 27. CashDirector will take the stage on September 25 at 12pm ET, during Demo Session 6, to highlight…

Continue Reading

FridaySep 21, 2018 12:38 pm

NetworkNewsBreaks – Finovate Highlights Upcoming Conferences, Provides FinovateFall Sneak Peek

Finovate, a leading producer of global fintech conferences, this morning highlighted its robust lineup of upcoming events, scheduled to take place in inviting global locales. These include FinovateAsia in Hong Kong and Shenzhen, China; FinovateAfrica in Cape Town, South Africa; and FinovateFall in New York City. “Our global Finovate conferences are premier events in the international fintech space and not-to-be-missed gatherings for anyone desiring to stay at the forefront of fintech innovation,” Greg Palmer, VP of Finovate, stated in the news release. “Whether you’re a banker, innovator, venture capitalist, or analyst, there’s something for you at Finovate.” The news release…

Continue Reading

FridaySep 21, 2018 12:14 pm

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Subsidiary and Payment Club Plan to Expand Operations

Net Element (NASDAQ: NETE) subsidiary Unified Payments, through a partnership with Payment Club, Inc., is launching subscription-based payment processing services (http://nnw.fm/eLiP8). A recent article discussing this reads: “Net Element develops multi-channel electronic payment solutions, among which is Unified Payments, a flexible mobile point-of-sale system that enables small and mid-sized businesses to accept cashless payments. … Payment Club provides payment processing services on a subscription-based model. Its co-founders recently announced completion of a $7 million financing deal. With the financial boost, Payment Club intends to expand its operations across the United States, hire key staff and open up facilities in which…

Continue Reading

FridaySep 21, 2018 11:56 am

NetworkNewsBreaks – Why Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) is “One to Watch”

Lithium-focused exploration company Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) is focused on unlocking the value of existing large-scale lithium brine resources in the U.S. that can swiftly be brought into production. A recent article discussing Standard Lithium reads: “The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes. …The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing…

Continue Reading

FridaySep 21, 2018 10:13 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) President Announces Launch of SingleCoin App in Interview on MoneyTV

SinglePoint (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” In this week’s episode, SinglePoint president Wil Ralston announced that the company’s SingleCoin application has gone live. “SingleCoin is live, it's launched on Android and iOS. We've launched at SinglePoint.com, you can now actually can see the preview and the links there to directly download the application,” SinglePoint president Wil Ralston stated in the interview. “All the things are in order; the commercial has been approved and it's going to…

Continue Reading

FridaySep 21, 2018 9:34 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF) to Present Clinical Trial Data at Two Upcoming NYC Conferences

BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, this morning announced that it will be presenting data from biomarker analyses of its clinical trials for advanced breast cancer at the Fourth International Cancer Immunotherapy Conference, as well as at The MicroCap Conference. Both events will take place in New York City. The first presentation, at the Fourth International Cancer Immunotherapy Conference, will take place on Sunday, September 30 at 11:45 am. The second, at The MicroCap Conference, will take place on Monday, October 1 at 4:30 pm. Per the update,…

Continue Reading

Contact us: 212.418.1217